All Barcelona Institute for Global Health articles
-
News
Rapid diagnostic tests improve diagnosis access to indigenous Paraguayan community for Chagas disease
A study has shown that combining rapid diagnostic tests (RDTs) with conventional serological tests proves to be a useful strategy for diagnosing Chagas disease in an indigenous community in the Paraguayan Chaco with its higher prevalence of the disease.
-
News
Exposure to air pollution associated with more hospital admissions for lower respiratory infections
New research shows that long-term exposure to PM2.5, PM10, NO2 and ozone (O3) air pollution is associated with more hospital admissions for lower respiratory tract infections in adults.
-
News
Meningitis has a much greater impact on child mortality than previously thought
New study reveals high rates of antibiotic-resistant bacteria in hospital-associated cases of meningitis in children under five years of age.
-
News
Study reveals stubborn mistrust in COVID-19 vaccine science
A new study sheds light on public trust in COVID-19 vaccine science and its impact on vaccine acceptance in the United States from 2021 to 2023, finding that around one-third of respondents expressed mistrust in the science behind COVID-19 vaccines.
-
News
Microorganisms can travel long distances in the troposphere
Air samples taken at altitudes up to 3,000 metres over Japan unveil the presence of a wide array of microbes, some of which are potentially pathogenic to humans, transported thousands of kilometers by aerosols originating in northeast China.
-
News
Innovative test diagnoses chagas disease in newborns
The LAMP molecular diagnostic test, coupled with a modified 3D printer to extract DNA, has a sensitivity comparable to PCR, and can be used in laboratories with limited resources.
-
News
Researchers advise strengthening immunity against COVID-19 in people with cancer
Researchers who led a study on the effectiveness of vaccines against COVID-19 among cancer patients in Catalonia, have recommended administering additional doses of the vaccine among this risk population.
-
News
A significant portion of the world’s population continues to trust vaccines, says survey in 23 countries
A substantial proportion of the world’s population remains willing to get vaccinated against diseases including COVID-19, according to a new survey across 23 countries that represent more than 60% of the world’s population.
-
News
COVID-19 vaccine effectiveness and fewer common side-effects most important factors in whether adults choose to get vaccinated
Concerns about the common side-effects of COVID-19 vaccines and their effectiveness are key to determining whether adults in Germany and the UK choose to get vaccinated against the virus, according to new research.
-
News
Scientists develop an innovative compound effective against malaria and leishmaniasis
Initially designed for malaria, this drug shows high efficacy against leishmaniasis, representing a unique and promising breakthrough for the treatment of both infections.
-
News
Study reveals impact of malaria interventions through routine sampling of pregnant women
Genomic analysis of the malaria parasite in pregnant women attending their first antenatal visit revealed reduced diversity in areas of southern Mozambique where elimination interventions were implemented.
-
News
People in prison are at very high risk of tuberculosis, even years after release
A study in Paraguay evaluates tuberculosis incidence during and after incarceration in a cohort of nearly 3,000 people.
-
News
Drug-resistant tuberculosis may be under-diagnosed, reveals genomic analysis
This genomic sequencing study, in southern Mozambique, is the first to characterise the drug resistance profile at the population level and identify mutations that escape routine diagnostic tests.
-
News
Prevalence of malaria infections varies among migrant populations
A systematic review shows that malaria parasite prevalence is highest in migrants from the Sub-Saharan region, particularly migrants from Central Africa.
-
News
Drugs targeting malaria in Mozambique are still effective
The drugs used to treat and prevent malaria in Mozambique are still effective, according to a genomic analysis of drug resistance markers in Plasmodium falciparum, carried out by the Barcelona Institute for Global Health (ISGlobal) and the Manhiça Health Research Center (CISM). Source: CDC/ Dr. Mae Mellvin Photomicrograph ...
-
News
Gold-based antibiotics shine through in battle against multi-drug resistant superbugs
Several gold-based compounds with the potential to treat multidrug-resistant ’superbugs’ have been identified in new research being presented at this year’s ECCMID.